The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...

Please provide your email address to receive an email when new articles are posted on . Findings showed use was associated with fatigue and lower health-related quality of life. The associations were ...

A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney ...

A new study found a link between certain types of acid reflux medications and dementia. Patients who took proton pump inhibitors consistently for more than 4.4 years had a greater risk of dementia ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a retired male over 65 and a former occasional cigar ...

The risk for dementia before age 90 years was significantly higher among people with a history of proton pump inhibitor (PPI) use and was highest among those diagnosed before age 70 years regardless ...

TOKYO, Jun 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today the launch of "Pariet S" (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn ...

"The finding of no association may offer relief for patients who need long-term proton pump inhibitor therapy in the treatment of gastroesophageal reflux disease or for other clear indications." ...

Sources of error that may lead to false association include PPI use shortly before diagnosis, short-term PPI use. (HealthDay News) — Long-term proton pump inhibitor ...